All Access to Advanced Health Institute articles
-
News$12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza
The Access to Advanced Health Institute (AAHI) has been awarded the first stage of funding for a $12.7-million project to develop a novel immune-stimulating adjuvant formulation that will improve the human immune response to vaccines.
-
NewsClinical trial finds temperature-stable TB vaccine is safe and prompts immune response
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system.
